rHu Albumin is Estimated to Witness High Growth Owing to Wide Applications in Critical Care Medicine
![]() |
rHu Albumin Market |
Recombinant human albumin (rHu Albumin) is a sterile preparation of
purified albumin produced by recombinant DNA technology. It is used to replace
lost fluid in conditions such as burns, shock, blood transfusions and surgery
where there has been substantial fluid loss from the circulatory system. rHu
Albumin maintains the balance of blood volume and aids in maintaining proper
blood pressure. It also serves as a carrier and transporter of nutrients and
medications throughout the body and assists in regulating blood pH and other
biochemical processes.
The global rHu Albumin Market is estimated to be valued at US$ 14.16 Mn
in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023
to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The wide applications of rHu Albumin in critical care medicine is estimated to
witness high growth over the forecast period. rHu Albumin is widely used for
volume expansion in conditions like burns and trauma where greater fluid
resuscitation is required. It is also indicated for hypoalbuminemia due to
liver failure and nephrotic syndrome. The increasing number of patients suffering
from such critical illnesses is expected to propel the growth of the rHu
Albumin Market over the next few years. Additionally, advantages of rHu Albumin
over plasma-derived albumin such as reduced risk of contamination and higher
stability is also anticipated to boost its adoption.
SWOT Analysis
Strength: rHu Albumin is a recombinant form of human serum albumin which is
similar to human serum albumin in composition, structure and function. This
provides advantages over other albumin products as it reduces risk of disease
transmission. rHu Albumin has a long shelf life of more than 2 years and is
stable at room temperature which reduces cold chain requirements and provides
logistical benefits.
Weakness: High production cost of rHu Albumin compared to plasma-derived
albumin increases its price. Dependence on cell culture technology and
fermentation process increases production complexity.
Opportunity: Increasing prevalence of hypoalbuminemia and albumin deficiency
disorders worldwide presents potential growth opportunities. Rising healthcare
expenditure in developing regions also supports market expansion. Growing
therapeutic applications of albumin in areas such as oncology, hematology, and
hepatology offer scope for additional revenues.
Threats: Stringent regulatory norms governing recombinant protein production
slows approval timelines. Risk of product failures and recalls due to
manufacturing defects negatively impact sales and brand reputation. Intense
competition from alternatives like plasma-derived human albumin threatens
market share.
Key Takeaways
The Global
rHu Albumin Market Share is expected to witness high growth over the
forecast period of 2023 to 2030 supported by a CAGR of 10%. The market was
valued at US$ 14.16 Mn in 2023 and is anticipated to reach US$ 26.57 Mn by 2030
as albumin finds increasing therapeutic usage.
Regional analysis: Asia Pacific region dominates the global rHu Albumin market
currently and is expected to maintain its leading position during the forecast
period. This can be attributed to rising healthcare investments, growing
incidences of protein deficiency disorders, and availability of local
manufacturers in the region. China, India and Japan represent major national
markets within Asia Pacific for rHu Albumin.
Key players: Key players operating in the rHu Albumin market are Merck KGaA,
HiMedia Laboratories Pvt. Ltd., Albumin Bioscience, Albumedix, ScienCell
Research Laboratories, Inc., InVitria, Lazuline Biotech Private Limited, Lee
Biosolutions, Inc., Abcam Plc, and Shandong Kingtone Biotechnology Co.,Ltd.
These companies are focused on expanding production capacities and global reach
through strategic collaborations to strengthen market share.
Get more insights on this topic: https://www.pressreleasebulletin.com/rhu-albumin-market-trends-size-and-share-analysis/
Comments
Post a Comment